{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T03:03:46Z","timestamp":1789700626516,"version":"4.0.1"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2026,8,15]],"date-time":"2026-08-15T00:00:00Z","timestamp":1786752000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,8,15]],"date-time":"2026-08-15T00:00:00Z","timestamp":1786752000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pflugers Arch - Eur J Physiol"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1007\/s00424-026-03203-x","type":"journal-article","created":{"date-parts":[[2026,8,15]],"date-time":"2026-08-15T02:00:27Z","timestamp":1786759227000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["NAPE-PLD: the healthy intersection of N-acylethanolamines and bile acids in physiology and diseases"],"prefix":"10.1007","volume":"478","author":[{"given":"Gianpiero","family":"Garau","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucia","family":"Chico","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maico","family":"Polzella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Fornai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,15]]},"reference":[{"issue":"5","key":"3203_CR1","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1124\/pharmrev.122.000600","volume":"75","author":"M Maccarrone","year":"2023","unstructured":"Maccarrone M, Di Marzo V, Gertsch J et al (2023) Goods and Bads of the Endocannabinoid System as a Therapeutic Target: Lessons Learned after 30 Years. Pharmacol Rev 75(5):885\u2013958. https:\/\/doi.org\/10.1124\/pharmrev.122.000600","journal-title":"Pharmacol Rev"},{"issue":"4","key":"3203_CR2","doi-asserted-by":"publisher","first-page":"100070","DOI":"10.1016\/j.pharmr.2025.100070","volume":"77","author":"FA Iannotti","year":"2025","unstructured":"Iannotti FA, Di Marzo V (2025) The endocannabinoidomes: Pharmacological redundancy and promiscuity, and multi-kingdom variety of sources and molecular targets. Pharmacol Rev 77(4):100070. https:\/\/doi.org\/10.1016\/j.pharmr.2025.100070","journal-title":"Pharmacol Rev"},{"issue":"1","key":"3203_CR3","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1038\/s41392-024-01811-6","volume":"9","author":"JS Fleishman","year":"2024","unstructured":"Fleishman JS, Kumar S (2024) Bile acid metabolism and signaling in health and disease: molecular mechanisms and therapeutic targets. Signal Transduct Target Ther 9(1):97. https:\/\/doi.org\/10.1038\/s41392-024-01811-6","journal-title":"Signal Transduct Target Ther"},{"issue":"7068","key":"3203_CR4","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1038\/nature04399","volume":"438","author":"FR Maxfield","year":"2005","unstructured":"Maxfield FR, Tabas I (2005) Role of cholesterol and lipid organization in disease. Nature 438(7068):612\u2013621. https:\/\/doi.org\/10.1038\/nature04399","journal-title":"Nature"},{"issue":"11","key":"3203_CR5","doi-asserted-by":"publisher","first-page":"2562","DOI":"10.1161\/ATVBAHA.118.311185","volume":"38","author":"P Rinne","year":"2018","unstructured":"Rinne P, Guillamat-Prats R, Rami M et al (2018) Palmitoylethanolamide Promotes a Proresolving Macrophage Phenotype and Attenuates Atherosclerotic Plaque Formation. Arterioscler Thromb Vasc Biol 38(11):2562\u20132575. https:\/\/doi.org\/10.1161\/ATVBAHA.118.311185","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"3203_CR6","doi-asserted-by":"publisher","unstructured":"Fan A, Wu X, Wu H et al (2014) Atheroprotective effect of oleoylethanolamide (OEA) targeting oxidized LDL. Gaetani S, ed. PLoS ONE 9(1):e85337. https:\/\/doi.org\/10.1371\/journal.pone.0085337","DOI":"10.1371\/journal.pone.0085337"},{"issue":"2","key":"3203_CR7","doi-asserted-by":"publisher","first-page":"R83","DOI":"10.1530\/JOE-20-0444","volume":"248","author":"FA Iannotti","year":"2021","unstructured":"Iannotti FA, Di Marzo V (2021) The gut microbiome, endocannabinoids and metabolic disorders. J Endocrinol 248(2):R83\u2013R97. https:\/\/doi.org\/10.1530\/JOE-20-0444","journal-title":"J Endocrinol"},{"issue":"1","key":"3203_CR8","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1038\/s41575-022-00682-y","volume":"20","author":"SM Brierley","year":"2023","unstructured":"Brierley SM, Greenwood-Van Meerveld B, Sarnelli G, Sharkey KA, Storr M, Tack J (2023) Targeting the endocannabinoid system for the treatment of abdominal pain in irritable bowel syndrome. Nat Rev Gastroenterol Hepatol 20(1):5\u201325. https:\/\/doi.org\/10.1038\/s41575-022-00682-y","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"1","key":"3203_CR9","doi-asserted-by":"publisher","first-page":"2672","DOI":"10.1038\/s41467-023-37864-4","volume":"14","author":"K Krishna Kumar","year":"2023","unstructured":"Krishna Kumar K, Robertson MJ, Thadhani E et al (2023) Structural basis for activation of CB1 by an endocannabinoid analog. Nat Commun 14(1):2672. https:\/\/doi.org\/10.1038\/s41467-023-37864-4","journal-title":"Nat Commun"},{"issue":"30","key":"3203_CR10","doi-asserted-by":"publisher","first-page":"e2401091121","DOI":"10.1073\/pnas.2401091121","volume":"121","author":"X Yang","year":"2024","unstructured":"Yang X, Zhou P, Shen S et al (2024) Entropy drives the ligand recognition in G-protein-coupled receptor subtypes. Proc Natl Acad Sci 121(30):e2401091121. https:\/\/doi.org\/10.1073\/pnas.2401091121","journal-title":"Proc Natl Acad Sci"},{"issue":"4","key":"3203_CR11","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1111\/1440-1681.13238","volume":"47","author":"H Tutunchi","year":"2020","unstructured":"Tutunchi H, Saghafi-Asl M, Ostadrahimi A (2020) A systematic review of the effects of oleoylethanolamide, a high\u2010affinity endogenous ligand of PPAR\u2010\u03b1, on the management and prevention of obesity. Clin Exp Pharmacol Physiol 47(4):543\u2013552. https:\/\/doi.org\/10.1111\/1440-1681.13238","journal-title":"Clin Exp Pharmacol Physiol"},{"issue":"3","key":"3203_CR12","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1038\/oby.2010.219","volume":"19","author":"T Wangensteen","year":"2011","unstructured":"Wangensteen T, Akselsen H, Holmen J, Undlien D, Retterst\u00f8l L (2011) A Common Haplotype in NAPEPLD Is Associated With Severe Obesity in a Norwegian Population-Based Cohort (the HUNT Study). Obesity 19(3):612\u2013617. https:\/\/doi.org\/10.1038\/oby.2010.219","journal-title":"Obesity"},{"issue":"7","key":"3203_CR13","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1038\/s41569-023-00847-5","volume":"20","author":"PL Valenzuela","year":"2023","unstructured":"Valenzuela PL, Carrera-Bastos P, Castillo-Garc\u00eda A, Lieberman DE, Santos-Lozano A, Lucia A (2023) Obesity and the risk of cardiometabolic diseases. Nat Rev Cardiol 20(7):475\u2013494. https:\/\/doi.org\/10.1038\/s41569-023-00847-5","journal-title":"Nat Rev Cardiol"},{"key":"3203_CR14","doi-asserted-by":"publisher","first-page":"108311","DOI":"10.1016\/j.pharmthera.2022.108311","volume":"240","author":"MJ Hurley","year":"2022","unstructured":"Hurley MJ, Bates R, Macnaughtan J, Schapira AHV (2022) Bile acids and neurological disease. Pharmacol Ther 240:108311. https:\/\/doi.org\/10.1016\/j.pharmthera.2022.108311","journal-title":"Pharmacol Ther"},{"issue":"3","key":"3203_CR15","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1016\/j.str.2014.12.018","volume":"23","author":"P Magotti","year":"2015","unstructured":"Magotti P, Bauer I, Igarashi M et al (2015) Structure of Human N -Acylphosphatidylethanolamine-Hydrolyzing Phospholipase D: Regulation of Fatty Acid Ethanolamide Biosynthesis by Bile Acids. Structure 23(3):598\u2013604. https:\/\/doi.org\/10.1016\/j.str.2014.12.018","journal-title":"Structure"},{"issue":"7","key":"3203_CR16","doi-asserted-by":"publisher","first-page":"1483","DOI":"10.1016\/j.cmet.2021.04.009","volume":"33","author":"A Castellanos-Jankiewicz","year":"2021","unstructured":"Castellanos-Jankiewicz A, Guzm\u00e1n-Quevedo O, F\u00e9nelon VS et al (2021) Hypothalamic bile acid-TGR5 signaling protects from obesity. Cell Metab 33(7):1483\u20131492e10. https:\/\/doi.org\/10.1016\/j.cmet.2021.04.009","journal-title":"Cell Metab"},{"issue":"9","key":"3203_CR17","doi-asserted-by":"publisher","first-page":"bqad116","DOI":"10.1210\/endocr\/bqad116","volume":"164","author":"S Higuchi","year":"2023","unstructured":"Higuchi S, Wood C, Nasiri RH et al (2023) The 16\u03b1-hydroxylated Bile Acid, Pythocholic Acid Decreases Food Intake and Increases Oleoylethanolamide in Male Mice. Endocrinology 164(9):bqad116. https:\/\/doi.org\/10.1210\/endocr\/bqad116","journal-title":"Endocrinology"},{"issue":"4","key":"3203_CR18","doi-asserted-by":"publisher","first-page":"R595","DOI":"10.1152\/ajpregu.00459.2017","volume":"315","author":"JD Brown","year":"2018","unstructured":"Brown JD, McAnally D, Ayala JE et al (2018) Oleoylethanolamide modulates glucagon-like peptide-1 receptor agonist signaling and enhances exendin-4-mediated weight loss in obese mice. Am J Physiol-Regul Integr Comp Physiol 315(4):R595\u2013R608. https:\/\/doi.org\/10.1152\/ajpregu.00459.2017","journal-title":"Am J Physiol-Regul Integr Comp Physiol"},{"issue":"4","key":"3203_CR19","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1038\/s41579-022-00805-x","volume":"21","author":"SL Collins","year":"2023","unstructured":"Collins SL, Stine JG, Bisanz JE, Okafor CD, Patterson AD (2023) Bile acids and the gut microbiota: metabolic interactions and impacts on disease. Nat Rev Microbiol 21(4):236\u2013247. https:\/\/doi.org\/10.1038\/s41579-022-00805-x","journal-title":"Nat Rev Microbiol"},{"issue":"11","key":"3203_CR20","doi-asserted-by":"publisher","first-page":"798","DOI":"10.1038\/s41577-024-01057-x","volume":"24","author":"MH Lee","year":"2024","unstructured":"Lee MH, Nuccio SP, Mohanty I et al (2024) How bile acids and the microbiota interact to shape host immunity. Nat Rev Immunol 24(11):798\u2013809. https:\/\/doi.org\/10.1038\/s41577-024-01057-x","journal-title":"Nat Rev Immunol"},{"issue":"1","key":"3203_CR21","doi-asserted-by":"publisher","first-page":"15927","DOI":"10.1038\/s41598-019-51799-1","volume":"9","author":"F Palese","year":"2019","unstructured":"Palese F, Pontis S, Realini N, Piomelli D (2019) A protective role for N-acylphosphatidylethanolamine phospholipase D in 6-OHDA-induced neurodegeneration. Sci Rep 9(1):15927. https:\/\/doi.org\/10.1038\/s41598-019-51799-1","journal-title":"Sci Rep"},{"issue":"6","key":"3203_CR22","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1038\/s41589-020-0528-7","volume":"16","author":"ED Mock","year":"2020","unstructured":"Mock ED, Mustafa M, Gunduz-Cinar O et al (2020) Discovery of a NAPE-PLD inhibitor that modulates emotional behavior in mice. Nat Chem Biol 16(6):667\u2013675. https:\/\/doi.org\/10.1038\/s41589-020-0528-7","journal-title":"Nat Chem Biol"},{"issue":"3","key":"3203_CR23","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1038\/oby.2010.219","volume":"19","author":"T Wangensteen","year":"2011","unstructured":"Wangensteen T, Akselsen H, Holmen J, Undlien D, Retterst\u00f8l L (2011) A Common Haplotype in NAPEPLD Is Associated With Severe Obesity in a Norwegian Population-Based Cohort (the HUNT Study). Obesity 19(3):612\u2013617. https:\/\/doi.org\/10.1038\/oby.2010.219","journal-title":"Obesity"},{"issue":"1","key":"3203_CR24","doi-asserted-by":"publisher","first-page":"5818","DOI":"10.1038\/s41598-018-23938-7","volume":"8","author":"KM Minor","year":"2018","unstructured":"Minor KM, Letko A, Becker D et al (2018) Canine NAPEPLD-associated models of human myelin disorders. Sci Rep 8(1):5818. https:\/\/doi.org\/10.1038\/s41598-018-23938-7","journal-title":"Sci Rep"},{"issue":"1","key":"3203_CR25","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1038\/s41467-018-08051-7","volume":"10","author":"A Everard","year":"2019","unstructured":"Everard A, Plovier H, Rastelli M et al (2019) Intestinal epithelial N-acylphosphatidylethanolamine phospholipase D links dietary fat to metabolic adaptations in obesity and steatosis. Nat Commun 10(1):457. https:\/\/doi.org\/10.1038\/s41467-018-08051-7","journal-title":"Nat Commun"},{"issue":"3","key":"3203_CR26","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1016\/j.chembiol.2025.01.008","volume":"32","author":"S Chiarugi","year":"2025","unstructured":"Chiarugi S, Margheriti F, De Lorenzi V et al (2025) NAPE-PLD is target of thiazide diuretics. Cell Chem Biol 32(3):449\u2013462e5. https:\/\/doi.org\/10.1016\/j.chembiol.2025.01.008","journal-title":"Cell Chem Biol"},{"issue":"4","key":"3203_CR27","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1002\/jimd.12060","volume":"42","author":"MP Wilson","year":"2019","unstructured":"Wilson MP, Plecko B, Mills PB, Clayton PT (2019) Disorders affecting vitamin B6 metabolism. J Inherit Metab Dis 42(4):629\u2013646. https:\/\/doi.org\/10.1002\/jimd.12060","journal-title":"J Inherit Metab Dis"},{"issue":"38","key":"3203_CR28","doi-asserted-by":"publisher","first-page":"19746","DOI":"10.1074\/jbc.M116.736876","volume":"291","author":"P Lunetti","year":"2016","unstructured":"Lunetti P, Damiano F, De Benedetto G et al (2016) Characterization of Human and Yeast Mitochondrial Glycine Carriers with Implications for Heme Biosynthesis and Anemia. J Biol Chem 291(38):19746\u201319759. https:\/\/doi.org\/10.1074\/jbc.M116.736876","journal-title":"J Biol Chem"},{"issue":"1","key":"3203_CR29","doi-asserted-by":"publisher","first-page":"978","DOI":"10.1038\/s41467-025-56130-3","volume":"16","author":"IA Pena","year":"2025","unstructured":"Pena IA, Shi JS, Chang SM et al (2025) SLC25A38 is required for mitochondrial pyridoxal 5\u2019-phosphate (PLP) accumulation. Nat Commun 16(1):978. https:\/\/doi.org\/10.1038\/s41467-025-56130-3","journal-title":"Nat Commun"},{"issue":"4","key":"3203_CR30","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1093\/ajh\/hpaf174","volume":"39","author":"G Garau","year":"2026","unstructured":"Garau G (2026) State of the Art Review: Thiazide Diuretics Exploit the Endocannabinoid System via NAPE-PLD. Am J Hypertens 39(4):482\u2013490. https:\/\/doi.org\/10.1093\/ajh\/hpaf174","journal-title":"Am J Hypertens"},{"issue":"7949","key":"3203_CR31","doi-asserted-by":"publisher","first-page":"788","DOI":"10.1038\/s41586-023-05718-0","volume":"614","author":"M Fan","year":"2023","unstructured":"Fan M, Zhang J, Lee CL, Zhang J, Feng L (2023) Structure and thiazide inhibition mechanism of the human Na\u2013Cl cotransporter. Nature 614(7949):788\u2013793. https:\/\/doi.org\/10.1038\/s41586-023-05718-0","journal-title":"Nature"},{"issue":"23","key":"3203_CR32","doi-asserted-by":"publisher","first-page":"2101837","DOI":"10.1002\/advs.202101837","volume":"8","author":"I Elorza Ridaura","year":"2021","unstructured":"Elorza Ridaura I, Sorrentino S, Moroni L (2021) Parallels between the Developing Vascular and Neural Systems: Signaling Pathways and Future Perspectives for Regenerative Medicine. Adv Sci 8(23):2101837. https:\/\/doi.org\/10.1002\/advs.202101837","journal-title":"Adv Sci"},{"issue":"1","key":"3203_CR33","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1186\/1471-2202-13-87","volume":"13","author":"LE Long","year":"2012","unstructured":"Long LE, Lind J, Webster M, Weickert CS (2012) Developmental trajectory of the endocannabinoid system in human dorsolateral prefrontal cortex. BMC Neurosci 13(1):87. https:\/\/doi.org\/10.1186\/1471-2202-13-87","journal-title":"BMC Neurosci"}],"container-title":["Pfl\u00fcgers Archiv - European Journal of Physiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00424-026-03203-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00424-026-03203-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00424-026-03203-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T02:27:14Z","timestamp":1789698434000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00424-026-03203-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,15]]},"references-count":33,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["3203"],"URL":"https:\/\/doi.org\/10.1007\/s00424-026-03203-x","relation":{},"ISSN":["0031-6768","1432-2013"],"issn-type":[{"value":"0031-6768","type":"print"},{"value":"1432-2013","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,15]]},"assertion":[{"value":"8 May 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 July 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 August 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 August 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","label":"Clinical trial number","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare the filed patent IT102025000013306. G.G., L.C. and M.P. are members of the staff of Laboratori Aliveda srl (Pisa, Italy).","order":2,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"74"}}